Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor - N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?

Isamu Tachibana*, Sean Q. Kern, Antoin Douglawi, Yan Tong, Mohammad Mahmoud, Timothy A. Masterson, Nabil Adra, Richard S. Foster, Lawrence H. Einhorn, Clint Cary

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor - N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?'. Together they form a unique fingerprint.

Medicine & Life Sciences